APO Research
Talk to an analyst

APO RESEARCH · REPORT

10-Valent Pneumococcal Polysaccharide Vaccine

10-Valent Pneumococcal Polysaccharide Vaccine is a vaccine product category defined by its pneumococcal antigen composition and formulation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which antigen composition and formulation define the vaccine?

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

Selected research

Market Structure

Global 10-Valent Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025177 pages

Choose your research edition.

Industry Research10-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 10-Valent Pneumococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 10-Valent Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine include GSK. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 10-Valent Pneumococcal Polysaccharide Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 10-Valent Pneumococcal Polysaccharide Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 10-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 10-Valent Pneumococcal Polysaccharide Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Company

GSK

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-filled Syringe

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

Hospital

Clinic

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Valent Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 10-Valent Pneumococcal Polysaccharide Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends Table 2. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers Table 3. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 4. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints Table 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers Table 9. Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application Table 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single Dose Vial Table 17. Major Manufacturers of Pre-filled Syringe Table 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 34. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 35. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 43. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 66. GSK Recent Development Table 67. Key Raw Materials Table 68. Raw Materials Key Suppliers Table 69. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors List Table 70. 10-Valent Pneumococcal Polysaccharide Vaccine Customers List Table 71. Research Programs/Design for This Report Table 72. Authors List of This Report Table 73. Secondary Sources Table 74. Primary Sources List of Figures Figure 1. 10-Valent Pneumococcal Polysaccharide Vaccine Product Image Figure 2. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (k units) Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 10-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single Dose Vial Image Figure 9. Pre-filled Syringe Image Figure 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 38. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
  1. 2.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
3 10-Valent Pneumococcal Polysaccharide Vaccine Market by Manufacturers
  1. 3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 10-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 10-Valent Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 10-Valent Pneumococcal Polysaccharide Vaccine Market by Type
  1. 4.1 10-Valent Pneumococcal Polysaccharide Vaccine Type Introduction
  2. 4.1.1 Single Dose Vial
  3. 4.1.2 Pre-filled Syringe
  4. 4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
  5. 4.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
  9. 4.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
5 10-Valent Pneumococcal Polysaccharide Vaccine Market by Application
  1. 5.1 10-Valent Pneumococcal Polysaccharide Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
  5. 5.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
  9. 5.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
6 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
  1. 6.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
  1. 7.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
  2. 7.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
  8. 7.2.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 9.1.1 10-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
  6. 9.2 10-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors
  9. 9.2.3 10-Valent Pneumococcal Polysaccharide Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst